首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Diabetes technology & therapeutics

缩写:DIABETES TECHNOL THE

ISSN:1520-9156

e-ISSN:1557-8593

IF/分区:7.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2719
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Marina Gradiser,Ines Bilic-Curcic,Ines Okun et al. Marina Gradiser et al.
Background: Lifestyle interventions focusing on diet and physical activity often fail to achieve sustained weight loss, primarily due to low adherence. Intermittently scanned continuous glucose monitoring (isCGM) may serv...
Yoshinori Kakutani,Tomoaki Morioka,Shoko Miyamoto et al. Yoshinori Kakutani et al.
Objective: Real-time continuous glucose monitoring (CGM) systems are beneficial for patients with diabetes by providing a comprehensive assessment of glycemic status and reducing hypoglycemia. However, their performance i...
Jennifer Ngan,Yee Wen Kong,Hanna C Jones et al. Jennifer Ngan et al.
We aimed to assess continuous ketone monitor (CKM) profiles in community-dwelling adults with type 1 diabetes. Two-weeks CKM (Abbott, Alameda, CA) run-in data (PARTNER study: ACTRN12624000448549) were analyzed by groups
Tom Wilkinson,Natalie Nanayakkara,David Burren et al. Tom Wilkinson et al.
Introduction: Current automated insulin delivery (AID) systems recommend manual insulin delivery prior to meals (hybrid closed-loop [HCL]). Data are needed on the efficacy of an AID system without meal announcement. ...
Eric Cucchi,Asem Ali,Yurima Guilarte-Walker et al. Eric Cucchi et al.
Objectives: Continuous glucose monitoring (CGM) devices are routinely used in the outpatient management of diabetes. They are not yet approved for use in intensive care units (ICUs). The main objective of this study was t...
Alexia Aouba,Bleuenn Dreves,Julia Morera et al. Alexia Aouba et al.
Introduction: Automated insulin delivery (AID) systems represent a major advancement in the management of type 1 diabetes (T1D). While their metabolic efficacy is well established, limited data are available on the impact...